Physiologically based pharmacokinetic (PBPK) modeling is valuable for drug development (Phase I). While PBPK models may share similar compartmental structures (e.g., blood, liver) for different species, a distinct set of physiological (e.g. compartmental volume and blood flow rate) and drug-specific (e.g. metabolism and clearance rates) parameters need to be used in different species. However, it […]